MedTrace Logo

Mood and Cognitive Outcome After Heart Transplantation (the MOODHEART Study)

NCT02035865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2021-08-09

No results posted yet for this study

Summary

The investigators aim at characterizing neuropsychiatric consequences of heart transplantation (HTX) and at assessing the impact of depressive symptoms after HTX on mortality and cardiac allograft vasculopathy (CAV).

Conditions

  • Psychiatric Diagnosis
  • Cognition Disorders

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Ira R. Hebold Haraldsen, MD/dr philos · Oslo University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035865 on ClinicalTrials.gov